Relationship of Periostin and ODI, EQ-5D
Recruiting
Observational Study
Intervertebral Disc Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 20 – 80
- Sex
- Any
- Study type
- Observational
- Participants needed
- 38 (estimated)
- Sponsor
- Keimyung University Dongsan Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The intervertebral disc degeneration (IVDD) is a widely recognized musculoskeletal disorder that impose a substantial socioeconomic burden and respresents one of the most important causes of low back pain. IVDD can result from a variety of factors, including aging, obesity, genetic predispositioin, degeneration of of the multifidus and psoas muscles, osteoporosis, inflammation, and oxidative stres…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* lumbar disc herniation
* lumbar spinal canal stenosis
* patients who have MRI
* patients who can fill in the ODI and EQ5D without other's help
Exclusion Criteria:
* allergic disease
* allergic rhinitis
* asthma
* atopic dermatitis
* chronic sinusitis
* history of cancer
* fr…
Contacts